• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    GE HealthCare Technologies (GEHC) Following Catholic Health Deal Looks Like A Buying Opportunity

    Simply Wall St·07/21/2026 02:21:16
    Listen to the news

    GE HealthCare Technologies (GEHC) has drawn fresh attention after Catholic Health agreed to a 10 year, approximately $500 million Care Alliance that focuses on advanced imaging, AI enabled tools, and system wide technology modernization.

    See our latest analysis for GE HealthCare Technologies.

    Despite a series of new partnerships and product announcements, including the Catholic Health Care Alliance and the Mayo Clinic MI-BET collaboration, GE HealthCare Technologies’ share price return has been under pressure. The stock is down 24.14% year to date and the 1 year total shareholder return is down 15.13%, indicating fading momentum even as interest in its imaging and AI capabilities increases.

    If GE HealthCare’s AI push has your attention, it may be a good moment to scan the wider field of healthcare AI opportunities using Simply Wall St’s 39 healthcare AI stocks

    GE HealthCare Technologies has been signing sizeable AI and imaging deals while the stock has fallen sharply this year. Is this a chance to buy into that story now, or a signal to wait for a different entry point as the valuation stacks up next?

    Most Popular Narrative: 21.2% Undervalued

    Against a last close of $62.83, the most followed narrative on GE HealthCare Technologies points to a higher fair value anchored in long term earnings and margin assumptions.

    The pipeline of new high impact products, like Radiopharmaceuticals, Total Body PET, and Photon Counting CT, is anticipated to drive future revenue growth and potentially improve margins.

    The focus on expanding recurring revenue, particularly in areas like digital solutions and advanced visualization, is expected to contribute positively to revenue stability and net margins.

    Read the complete narrative.

    Curious what has to happen for that fair value to stack up? The narrative leans on steady revenue expansion, firmer margins, and a future earnings multiple that assumes investors stay willing to pay up.

    Result: Fair Value of $79.72 (UNDERVALUED)

    Have a read of the narrative in full and understand what's behind the forecasts.

    However, the GE HealthCare Technologies narrative still faces pressure from tariff related earnings impacts and uncertainty around China. This could weaken the case for that undervaluation.

    Find out about the key risks to this GE HealthCare Technologies narrative.

    Next Steps

    If the mixed tone around GE HealthCare Technologies leaves you unsure, consider acting while the data is top of mind and weigh the 4 key rewards and 1 important warning sign against your own judgment.

    Looking for more investment ideas beyond GE HealthCare Technologies?

    If GE HealthCare Technologies has sharpened your focus on where to put fresh capital next, do not stop with a single stock when the data can work harder for you.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.